Stock listing
Bursa Malaysia:SUPERMX Supermax Corp. Bhd. Share Price
Home listing (Bursa Malaysia) of Supermax Corp. Bhd.
Follow Supermax Corp. Bhd. into a list and get an email when it puts out news.
Share price · MYX:SUPERMX
0.42 MYR +0.01 (+2.4%)
Close on Nov 20, 2026
- Day range
- 0.40 – 0.43 MYRNov 20, 2026
- Volume
- 12.34M sharesNov 20, 2026
- Market cap
- 1.28B MYRAt the close on Nov 20, 2026 · price × 3.06B shares outstanding
- Traded on an average day
- 7.93M MYRMedian day 16.60M shares · 3 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · MYX:SUPERMX · MYR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 0.42 | +0.01 | +2.4% | 0.405 | 0.43 | 0.40 | 12,335,800 | |
| 0.41 | +0.01 | +2.5% | 0.405 | 0.415 | 0.40 | 6,861,700 | |
| 0.40 | -0.01 | -2.4% | 0.405 | 0.415 | 0.395 | 9,477,400 | |
| 0.41 | -0.005 | -1.2% | 0.41 | 0.415 | 0.395 | 13,222,400 | |
| 0.415 | +0.005 | +1.2% | 0.405 | 0.42 | 0.40 | 9,144,500 | |
| 0.41 | -0.02 | -4.7% | 0.43 | 0.435 | 0.405 | 14,825,600 | |
| 0.43 | -0.03 | -6.5% | 0.46 | 0.46 | 0.43 | 16,921,200 | |
| 0.46 | +0.015 | +3.4% | 0.45 | 0.46 | 0.44 | 9,349,900 | |
| 0.445 | -0.005 | -1.1% | 0.455 | 0.455 | 0.435 | 8,620,600 | |
| 0.45 | -0.015 | -3.2% | 0.45 | 0.47 | 0.44 | 20,903,000 | |
| 0.465 | -0.015 | -3.1% | 0.48 | 0.48 | 0.455 | 16,614,100 | |
| 0.48 | +0.02 | +4.3% | 0.46 | 0.485 | 0.45 | 24,590,000 | |
| 0.46 | -0.01 | -2.1% | 0.465 | 0.475 | 0.455 | 18,300,800 | |
| 0.47 | -0.01 | -2.1% | 0.48 | 0.485 | 0.465 | 16,624,200 | |
| 0.48 | 0.00 | 0.0% | 0.48 | 0.50 | 0.475 | 26,495,900 | |
| 0.48 | 0.00 | 0.0% | 0.48 | 0.485 | 0.46 | 23,364,400 | |
| 0.48 | -0.005 | -1.0% | 0.485 | 0.49 | 0.475 | 12,586,300 | |
| 0.485 | +0.01 | +2.1% | 0.475 | 0.49 | 0.465 | 26,098,800 | |
| 0.475 | +0.02 | +4.4% | 0.455 | 0.475 | 0.445 | 22,921,800 | |
| 0.455 | +0.02 | +4.6% | 0.435 | 0.46 | 0.43 | 21,145,800 | |
| 0.435 | -0.005 | -1.1% | 0.435 | 0.44 | 0.425 | 8,821,400 | |
| 0.44 | -0.005 | -1.1% | 0.445 | 0.455 | 0.435 | 11,665,200 | |
| 0.445 | +0.015 | +3.5% | 0.43 | 0.45 | 0.42 | 16,535,800 | |
| 0.43 | -0.015 | -3.4% | 0.445 | 0.46 | 0.43 | 18,152,800 | |
| 0.445 | +0.005 | +1.1% | 0.44 | 0.46 | 0.44 | 12,390,600 | |
| 0.44 | -0.02 | -4.3% | 0.46 | 0.465 | 0.435 | 18,577,000 | |
| 0.46 | +0.025 | +5.7% | 0.435 | 0.46 | 0.425 | 23,435,000 | |
| 0.435 | +0.02 | +4.8% | 0.41 | 0.44 | 0.41 | 16,663,000 | |
| 0.415 | -0.02 | -4.6% | 0.435 | 0.44 | 0.405 | 16,710,500 | |
| 0.435 | -0.01 | -2.2% | 0.45 | 0.45 | 0.43 | 12,806,900 | |
| 0.445 | 0.00 | 0.0% | 0.445 | 0.465 | 0.44 | 27,425,500 | |
| 0.445 | -0.015 | -3.3% | 0.465 | 0.51 | 0.435 | 79,012,602 | |
| 0.46 | +0.025 | +5.7% | 0.44 | 0.465 | 0.43 | 44,061,100 | |
| 0.435 | +0.015 | +3.6% | 0.425 | 0.45 | 0.425 | 17,151,300 | |
| 0.42 | +0.02 | +5.0% | 0.405 | 0.435 | 0.405 | 16,628,600 | |
| 0.40 | +0.005 | +1.3% | 0.395 | 0.405 | 0.39 | 4,697,100 | |
| 0.395 | +0.005 | +1.3% | 0.395 | 0.405 | 0.385 | 10,804,400 | |
| 0.39 | 0.00 | 0.0% | 0.39 | 0.40 | 0.38 | 7,939,400 | |
| 0.39 | -0.03 | -7.1% | 0.425 | 0.425 | 0.385 | 18,746,100 | |
| 0.42 | +0.005 | +1.2% | 0.415 | 0.435 | 0.415 | 16,720,800 | |
| 0.415 | +0.02 | +5.1% | 0.40 | 0.43 | 0.395 | 26,279,800 | |
| 0.395 | +0.005 | +1.3% | 0.385 | 0.41 | 0.385 | 11,477,300 | |
| 0.39 | -0.025 | -6.0% | 0.415 | 0.415 | 0.39 | 10,405,400 | |
| 0.415 | +0.025 | +6.4% | 0.39 | 0.415 | 0.38 | 13,142,200 | |
| 0.39 | -0.005 | -1.3% | 0.39 | 0.395 | 0.375 | 17,430,700 | |
| 0.395 | -0.01 | -2.5% | 0.405 | 0.405 | 0.385 | 16,594,600 | |
| 0.405 | 0.00 | 0.0% | 0.405 | 0.405 | 0.405 | 0 | |
| 0.405 | -0.02 | -4.7% | 0.425 | 0.425 | 0.395 | 22,883,800 | |
| 0.425 | +0.005 | +1.2% | 0.42 | 0.455 | 0.42 | 33,506,700 | |
| 0.42 | -0.01 | -2.3% | 0.435 | 0.45 | 0.415 | 64,390,300 | |
| 0.43 | +0.08 | +22.9% | 0.35 | 0.44 | 0.35 | 78,752,100 | |
| 0.35 | -0.005 | -1.4% | 0.355 | 0.355 | 0.34 | 6,855,400 | |
| 0.355 | -0.015 | -4.1% | 0.375 | 0.375 | 0.35 | 14,537,500 | |
| 0.37 | 0.00 | 0.0% | 0.37 | 0.38 | 0.35 | 12,050,400 | |
| 0.37 | -0.005 | -1.3% | 0.37 | 0.375 | 0.36 | 9,592,900 | |
| 0.375 | +0.035 | +10.3% | 0.345 | 0.39 | 0.345 | 35,900,400 | |
| 0.34 | +0.02 | +6.3% | 0.315 | 0.345 | 0.315 | 22,597,300 | |
| 0.32 | -0.005 | -1.5% | 0.325 | 0.33 | 0.315 | 9,232,500 | |
| 0.325 | 0.00 | 0.0% | 0.325 | 0.325 | 0.325 | 0 | |
| 0.325 | -0.025 | -7.1% | 0.345 | 0.35 | 0.325 | 13,779,100 | |
| 0.35 | +0.04 | +12.9% | 0.33 | 0.365 | 0.33 | 49,634,000 | |
| 0.31 | 0.00 | 0.0% | 0.31 | 0.325 | 0.305 | 10,023,900 | |
| 0.31 | 0.00 | 0.0% | 0.31 | 0.31 | 0.31 | 0 | |
| 0.31 | +0.045 | +17.0% | 0.27 | 0.315 | 0.27 | 32,512,700 | |
| 0.265 | -0.01 | -3.6% | 0.27 | 0.27 | 0.265 | 1,101,200 | |
| 0.275 | 0.00 | 0.0% | 0.275 | 0.275 | 0.265 | 3,779,900 |
- Ticker
- Bursa Malaysia:SUPERMX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Bursa Malaysia
- Currency
- MYR
What changed lately
Latest news release · May 28, 2026
Supermax Corporation Q3 Loss Attributable To Equity Holders 41.14 Million RGT
Latest news
Supermax Corp. Bhd. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 3 in the last 12 months · 5 in all · newest May 28, 2026 · oldest 2025
Where Supermax Corp. Bhd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Bursa Malaysia:SUPERMX · Home listing · This page | Bursa Malaysia | Malaysia | MYR |
| OTC:SPMXF | OTC | United States | USD |
Valuation
EV/sales 1.2× against a median of 4.1×: 2nd lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 886.3M MYR
- P/E
- Loss
- EV/sales
- 1.2×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 0.3×
- Gross margin
- 18.9%
- Operating margin
- −28.4%
- Net margin
- −20.9%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Supermax Corp. Bhd. · MYX:SUPERMX | US$312.4M | US$215.6M | n/a | 1.2× | n/a | 0.3× | −20.9% | 0.1× | n/a |
| Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A · SZSE:301290 | US$330.8M | US$220.5M | 29.6× | 3.4× | n/a | 1.0× | 17.2% | 0.1× | n/a |
| ACRO Biomedical Co., Ltd. · TPEX:6748 | US$327.3M | US$299.5M | n/a | 258× | n/a | 10.1× | −216.1% | 0.0× | n/a |
| Medcaptain Medical Technology Co. Ltd. Class H · HKEX:2041 | US$325.9M | US$288.8M | 44.4× | 1.2× | 9.7× | 1.1× | 3.0% | 0.1× | n/a |
| Yantai Zhenghai Bio-Tech Co. Ltd. Class A · SZSE:300653 | US$325.8M | US$231.2M | 34.2× | 4.8× | n/a | 2.4× | 19.9% | 0.0× | n/a |
| CapsoVision, Inc. · NASDAQ:CV | US$325.1M | US$304.1M | n/a | 21.9× | n/a | 12.3× | −210.1% | 0.0× | 0.88 |
| NIOX Group PLC · LSE:NIOX | US$318.1M | US$297.0M | 34.7× | 4.7× | 15.3× | 3.7× | 14.4% | 0.0× | n/a |
| Nanjing Medlander Medical Technology Co. Ltd. Class A · SSE:688273 | US$315.5M | US$208.7M | 33.0× | 3.6× | n/a | 1.5× | 16.6% | 0.0× | n/a |
| Chongqing Xishan Science and Technology Co., Ltd. Class A · SSE:688576 | US$301.5M | US$216.0M | n/a | 5.2× | n/a | 1.2× | −19.2% | 0.0× | n/a |
| Sanara MedTech Inc. · NASDAQ:SMTI | US$299.1M | US$329.0M | n/a | 2.9× | 34.4× | 39.0× | −2.7% | 6.1× | 0.49 |
| Peijia Medical Ltd. · HKEX:9996 | US$297.8M | US$280.7M | n/a | 2.6× | n/a | 1.1× | −28.5% | 0.3× | n/a |
| Median of the others | US$321.6M | US$284.7M | 34.2× | 4.1× | 15.3× | 2.0× | 0.2% | 0.0× | 0.69 |
Forecasts
Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.
- Price target
- 0.30 MYR · Analysts' mean
- EPS, year to Jun 2027
- -0.004 · 3 analysts
- Revenue, year to Jun 2027
- 937M · 4 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Tan Chee Keong | Chief Executive Officer |
| Dato' Seri Thai Kim Sim | Executive Chairman |
Board
| Director | Role |
|---|---|
| Dato' Seri Thai Kim Sim | Executive Chairman |
| Albert Saychuan Cheok | Independent Non-Executive Director |
| Dato' Ting Heng | Non-Executive Director |
| Gan Kim Khoon | Independent Non-Executive Director |
| Rozita Binti Abdul Rahman | Independent Non-Executive Director |
| Tan Chee Keong | Chief Executive Officer |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Aug 26, 2026 | +12.9% |
| Q1 2026 | May 19, 2026 · Before open | |
| Q4 2025 | Feb 23, 2026 · Before open | |
| Q3 2025 | Nov 26, 2025 · Before open | |
| Q2 2025 | Aug 26, 2025 · Before open | |
| Q1 2025 | May 21, 2025 · Before open | |
| Q4 2024 | Feb 24, 2025 · Before open | |
| Q3 2024 | Nov 28, 2024 · Before open | |
| Q2 2024 | Aug 28, 2024 · Before open | |
| Q1 2024 | May 28, 2024 · After close |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Feb 20, 2024 · Before open | |
| Q3 2023 | Nov 29, 2023 · Before open | |
| Q2 2023 | Aug 29, 2023 · Before open | |
| Q1 2023 | May 18, 2023 · Before open | |
| Q4 2022 | Feb 20, 2023 · Before open | |
| Q3 2022 | Nov 22, 2022 · Before open | |
| Q2 2022 | Aug 22, 2022 · Before open | |
| Q1 2022 | May 25, 2022 | |
| Q4 2021 | Feb 22, 2022 | |
| Q3 2021 | Nov 17, 2021 |
Financials
Annual, in MYR
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 737.1M | 781.9M | 646.2M | 821.1M | 2.69B | 7.16B | 2.13B | 1.54B | 1.30B | 1.13B |
| Cost of revenue | 954.6M | 1.03B | 528.3M | 669.9M | 1.14B | 1.61B | 1.02B | 1.02B | 865.2M | 762.7M |
| Gross profit | -217.6M | -251.3M | 117.8M | 151.2M | 1.55B | 5.56B | 1.11B | 513.3M | 439.3M | 364.2M |
| Selling, general and administrative | 131.1M | 130.4M | 147.4M | 171.7M | 190.4M | 136.1M | 64.8K | 64.8K | 64.8K | |
| Operating income | -217.6M | -251.3M | -174.3M | -182.3M | 1.07B | 5.03B | 697.2M | 192.1M | 175.9M | 119.0M |
| Depreciation and amortization | 121.1M | 79.0M | 68.4M | 85.4M | 73.9M | 68.8M | 61.7M | 45.1M | 41.8M | 41.3M |
| EBITDA | -96.5M | -172.4M | -105.9M | -96.9M | 1.14B | 5.10B | 758.9M | 237.2M | 217.7M | 160.3M |
| Interest expense | 7.03M | 7.86M | 5.23M | 7.22M | 5.71M | 8.11M | 17.1M | 19.7M | 14.0M | 11.1M |
| Income before tax | -206.0M | -210.6M | -176.0M | -189.5M | 1.06B | 5.02B | 680.2M | 172.4M | 161.9M | 107.9M |
| Income tax | -51.5M | -46.5M | 3.63M | -18.1M | 302.4M | 1.09B | 145.4M | 49.3M | 51.8M | 37.6M |
| Net income | -153.9M | -160.4M | -175.6M | -140.9M | 718.9M | 3.82B | 524.8M | 123.1M | 106.7M | 67.2M |
| Earnings per share, basic | -0.05 | -0.05 | -0.06 | -0.05 | 0.27 | 1.19 | 0.10 | 0.04 | 0.03 | 0.02 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 612.3M | 866.3M | 1.33B | 2.15B | 3.03B | 3.78B | 1.19B | 173.8M | 145.2M | 156.1M |
| Short-term investments | 7.19K | 6.96K | 6.73K | 6.51K | 3.47M | 2.95M | -375.1K | -388.1K | -401.2K | -414.3K |
| Receivables | 177.6M | 97.0M | 95.8M | 451.2M | 672.1M | 1.35B | 458.5M | 272.4M | 202.1M | 239.7M |
| Inventory | 249.5M | 190.8M | 181.9M | 157.2M | 267.6M | 518.5M | 253.2M | 181.9M | 187.8M | 189.7M |
| Current assets | 1.18B | 1.31B | 1.93B | 2.76B | 3.98B | 5.65B | 1.91B | 635.7M | 572.1M | 638.6M |
| Property, plant and equipment | 2.89B | 2.69B | 2.24B | 1.73B | 1.45B | 1.09B | 965.2M | 895.5M | 878.3M | |
| Goodwill | 0 | 28.7M | 28.7M | 28.7M | 28.7M | 28.7M | ||||
| Total assets | 4.27B | 4.41B | 4.84B | 5.25B | 5.96B | 7.39B | 3.20B | 1.84B | 1.70B | 1.79B |
| Accounts payable | 114.3M | 58.8M | 89.0M | 209.5M | 144.9M | 273.2M | 189.7M | 142.1M | 125.2M | 112.4M |
| Current liabilities | 399.9M | 298.0M | 318.0M | 497.6M | 805.1M | 2.37B | 1.51B | 601.9M | 566.2M | 570.6M |
| Long-term debt | 13.4M | 13.6M | 1.67M | 1.91M | 31.0M | 61.5M | 100.1M | 60.8M | 61.2M | 106.5M |
| Total debt | 214.6M | 148.6M | 130.3M | 104.4M | 232.5M | 262.3M | 330.4M | 391.6M | 436.2M | 450.5M |
| Total liabilities | 413.3M | 312.4M | 374.1M | 554.3M | 924.8M | 2.50B | 1.65B | 708.5M | 677.0M | 719.7M |
| Shareholders' equity | 3.85B | 4.08B | 4.45B | 4.60B | 4.87B | 4.76B | 1.53B | 1.12B | 1.01B | 1.07B |
| Shares outstanding | 3.08B | 3.08B | 3.09B | 2.64B | 2.64B | 3.22B | 5.52B | 2.81B | 3.39B | 2.87B |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 48.1M | -36.4M | -247.0M | -79.1M | 343.7M | 3.63B | 1.30B | 235.1M | 177.2M | 120.8M |
| Capital spending | -299.6M | -324.0M | -528.9M | -610.5M | -448.7M | -448.4M | -191.1M | -112.2M | -58.9M | -111.3M |
| Free cash flow | -251.5M | -360.4M | -775.9M | -689.6M | -105.0M | 3.18B | 1.11B | 122.8M | 118.3M | 9.44M |
| Cash from investing | -299.1M | -322.9M | -545.5M | -604.3M | -351.0M | -451.2M | -191.2M | -112.2M | -55.1M | -110.2M |
| Cash from financing | 62.7M | 52.1M | -20.5M | -286.9M | -765.1M | -678.6M | -150.3M | -104.0M | -126.4M | 20.1M |
| Dividends paid | 0 | -91.7M | -133.9M | -659.3M | -443.9M | -443.9M | -32.8M | -75.7M | -26.9M | |
| Share buybacks | 0 | -12.9M | -11.8M | -74.9M | -42.2M | -164.3M | -67.2M | -7.71M | -22.7M | -7.78M |
| Change in cash | -255.8M | -466.8M | -812.9M | -882.7M | -747.4M | 2.59B | 1.01B | 28.6M | -10.9M | 31.1M |
Cap table
Built by 6ix from Supermax Corp. Bhd.’s releases
- Common shares
- 3,057,253,823
- Fully diluted
- 3,057,253,823
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 3,057,253,823 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 3,057,253,823 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Albert Saychuan Cheok | Independent Non-Executive Director · Since at least Nov 5, 2026 |
| Dato' Seri Thai Kim Sim | Executive Chairman · Since at least Nov 5, 2026 |
| Dato' Ting Heng | Non-Executive Director · Since at least Nov 5, 2026 |
| Gan Kim Khoon | Independent Non-Executive Director · Since at least Nov 5, 2026 |
| Rozita Binti Abdul Rahman | Independent Non-Executive Director · Since at least Nov 5, 2026 |
| Tan Chee Keong | Chief Executive Officer · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Supermax Corp. Bhd.